ONC-127

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameONC-127
Drug Alias Nameglycolysis inhibitor (MD Anderson Cancer Center/Oncolin Therapeutics)ONC-127
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycolysis pathway modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBreitling Energy Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A